Gilead Sciences
GILD
#98
Rank
S$220.98 B
Marketcap
S$178.04
Share price
1.45%
Change (1 day)
19.13%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of December 2025 : S$29.11 Billion

According to Gilead Sciences's latest financial reports the company has S$29.11 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$S$29.03 B11%
2024-12-31$S$26.16 B-12.93%
2023-12-31$S$30.04 B5.67%
2022-12-31$S$28.43 B-0.15%
2021-12-31$S$28.47 B18.13%
2020-12-31$S$24.10 B-21.06%
2019-12-31$S$30.53 B3.8%
2018-12-31$S$29.41 B7.29%
2017-12-31$S$27.42 B-2.16%
2016-12-31$S$28.02 B3.65%
2015-12-31$S$27.03 B29.34%
2014-12-31$S$20.90 B40.47%
2013-12-31$S$14.88 B27.5%
2012-12-31$S$11.67 B31.23%
2011-12-31$S$8.89 B12.78%
2010-12-31$S$7.88 B-13.65%
2009-12-31$S$9.13 B43%
2008-12-31$S$6.38 B23.27%
2007-12-31$S$5.18 B80.79%
2006-12-31$S$2.86 B-43.16%
2005-12-31$S$5.04 B65.17%
2004-12-31$S$3.05 B79.11%
2003-12-31$S$1.70 B71.89%
2002-12-31$S$0.99 B18.36%
2001-12-31$S$0.83 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$104.96 B 260.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$111.69 B 283.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-S$4.16 Billion-114.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$34.15 B 17.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.14 B-61.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$23.49 B-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$3.50 B-87.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$24.02 B-17.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.78 B 132.83%๐Ÿ‡บ๐Ÿ‡ธ USA